(Bloomberg) -- Pfizer Inc.’s Tukysa, when given as part of the initial treatment for an advanced form of breast cancer, delayed tumor growth by more than eight months, according to a study that may ...

Pfizer (PFE) is reducing its Swiss workforce, with plans to cut its employee count to about 70 by the end of 2025 from 300 amid a broader cost-cutting drive, Bloomberg News reported, citing people ...

US-based pharmaceutical giant Pfizer is set to cut hundreds of jobs in Switzerland as part of the company's multi-year cost reduction program, reported the news agency Bloomberg, citing people aware ...

(Bloomberg) -- A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of blood disorders. The death occurred on Dec. 14 after the ...